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Abstract
Background: Peripheral arterial disease (PAD) is common in older people. An ankle-brachial index (ABI) < 0.9 can be
used as an indicator of PAD. Patients with low ABI have increased mortality and a higher risk of serious cardiovascular
morbidity. However, because 80% of the patients are asymptomatic, PAD remains unrecognised in a large group of
patients. The aims of this study were 1) to examine the prevalence of reduced ABI in subjects aged 80 and over, 2) to
determine the diagnostic accuracy of the medical history and clinical examination for reduced ABI and 3) to
investigate the difference in functioning and physical activity between patients with and without reduced ABI.
Methods: A cross-sectional study embedded within the BELFRAIL study. A general practitioner (GP) centre, located in
Hoeilaart, Belgium, recruited 239 patients aged 80 or older. Only three criteria for exclusion were used: urgent
medical need, palliative situation and known serious dementia. The GP recorded the medical history and performed
a clinical examination. The clinical research assistant performed an extensive examination including Mini-Mental State
Examination (MMSE), Geriatric Depression Scale (GDS-15), Activities of Daily Living (ADL), Tinetti test and the LASA
Physical Activity Questionnaire (LAPAQ). ABI was measured using an automatic oscillometric appliance.
Results: In 40% of patients, a reduced ABI was found. Cardiovascular risk factors were unable to identify patients
with low ABI. A negative correlation was found between the number of cardiovascular morbidities and ABI.
Cardiovascular morbidity had a sensitivity of 65.7% (95% CI 53.4-76.7) and a specificity of 48.6% (95% CI 38.7-58.5).
Palpation of the peripheral arteries showed the highest negative predictive value (77.7% (95% CI 71.8-82.9)). The
LAPAQ score was significantly lower in the group with reduced ABI.
Conclusion: The prevalence of PAD is very high in patients aged 80 and over in general practice. The clinical
examination, cardiovascular risk factors and the presence of cardiovascular morbidity were not able to identify
patients with a low ABI. A screening strategy for PAD by determining ABI could be considered if effective
interventions for those aged 80 and over with a low ABI become available through future research.
Background
Peripheral arterial disease (PAD) refers to atherosclero-
tic occlusive disease of the arterial system distal to the
aortic bifurcation and is a relatively common disorder in
older persons [1]. A Dutch study found a PAD preva-
lence of 19.1% in subjects aged 55 and older, and this
prevalence increased with age [1]. The clinical signs of
PAD have a significant impact on quality of life, ranging
from intermittent claudication to pain symptoms at rest,
arterial ulceration, necrosis and even gangrene in the
later stages [2]. In agreement with the approach fol-
lowed by Fowkes et al [3] and by Schroll and Munck [4]
PAD was considered present when the ABI was lower
than 0.90 in at least one leg, a threshold value used in
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does have an ABI of less than 0.9 yet experiences no
symptoms. Moreover, only 22% of patients with PAD
experience symptoms [7]. PAD may also be regarded as
a marker for cardiovascular disease in people over 65
years. The lower the ABI, the more likely it will be signs
of atherosclerosis are present [8]. Also, patients with
subclinical PAD more frequently have signs of cardio-
vascular disease, such as hypertension, carotid stenosis,
concomitant ECG abnormalities, angina pectoris or a
previous history of myocardial infarction [9]. Diehm
et al. showed that patients with PAD have increased
mortality and a higher risk of serious cardiovascular
morbidity [10-14].
The conventional way of calculating ABI is the Doppler
method, in which the quotient between the blood pres-
sure measured at the ankle and the blood pressure mea-
sured at the arm of the patient is calculated. However, in
everyday practice, this technique is not frequently used
[15]. This method demands regular practice and an
experienced researcher or clinician [16]. Recently, a new
method has been developed for the calculation of ABI
using an automatic oscillometric blood pressure reading
of the arm and the ankle. This method is simple to carry
out, requires less training and has been validated in sev-
eral studies [17-20].
However, patient groups for whom ABI measurement
would be useful have not yet been clearly defined. Further-
more, uncertainty still exists concerning the need to
screen for PAD; however, because 80% of the patients are
asymptomatic, a large group of patients remain unrecog-
nised [21,22]. Moreover, subjects aged 80 and over are
often underrepresented in studies or even excluded by
design. There is a growing consciousness that study results
from younger patient groups cannot simply be extrapo-
lated to the oldest old [23].
The aims of this study were 1) to determine the preva-
lence of reduced ABI (< 0.9) in subjects aged 80 and
over, 2) to discover whether a medical history and clinical
examination can identify patients with reduced ABI and
3) to investigate the difference in function and physical
activity between patients with and without reduced ABI.
Methods
BELFRAIL study
This cross-sectional study was embedded within the
BELFRAIL study. The BELFRAIL study is a prospective,
observational, population-based cohort study, and its
aim is to gain improved insight into the epidemiology
and pathophysiology of chronic diseases in subjects aged
80 and over [24]. The study protocol has been approved
by the Biomedical Ethics Committee of the Medical
School of the Université Catholique de Louvain of Brus-
sels (B40320084685).
Patient selection
After the initial cohort was constituted (n = 593), 19
subjects refused to continue and five died before the
examinations were started (Figure 1). A total of 567
patients from three different regions of Belgium: the
Dinant region (17 GP practices), Brussels (2 GP prac-
tices) and the Druivenstreek (10 GP practices) were
included in the definitive BELFRAIL cohort. For this
s t u d yo n l yt h ep a t i e n t sf r o mt h eG Pp r a c t i c eo fH o e i -
laart (Druivenstreek) were selected (n = 239).
This GP practice consists of five doctors and two trai-
nee GPs. Between March 2009 and July 2009, every
patient aged 80 or older who came in for a consultation
or was visited at home (including care homes and retire-
ment homes) was invited to participate in the BELF-
RAIL study. Only three criteria for exclusion were used:
urgent medical need, palliative situation and known
serious dementia (MMSE < 15/30).
After informed consent (by the patient and the caregiver
if MMSE < 18/30) the participating patients were exam-
ined by the GP and a clinical research assistant (CRA).
The CRA was a nurse, a psychologist or a biomedical
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Figure 1 BELFRAIL study participants flow-chart.
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Page 2 of 9scientist and performed an extensive examination includ-
ing performance testing and questionnaires following a
standardised protocol.
Examination by the GP
The GP recorded known cardiovascular risk factors and
the previous medical history of the patient. Indicators of
the cardiovascular risk profile were hypertension, hyperli-
pidaemia, type 2 diabetes mellitus, smoking (either current
or ex-smoker) and BMI > 30. Cardiac morbidities were
defined as a positive response for the history of angina
pectoris or acute myocardial infarction, an episode of
decompensated heart failure, chronic atrial fibrillation or
other rhythm disturbances and a previous history of
PTCA or stent and coronary surgery. Other cardiovascular
morbidities consisted of previous TIA or CVA, known
PAD and a previous history of arterial surgery. The GP
then carried out a standardised clinical examination. The
pulses of the lower limbs were palpated at the point of the
arteria dorsalis pedis or arteria tibialis posterior. If the
artery was palpable the clinical examination was negative,
if not it was positive.
Investigation by the CRA
Mini-Mental State Examination (MMSE)
The MMSE tests the cognitive function of the patient
with a score ranging from 0 to 30 (maximum score).
Orientation in time and space is tested, as are memory,
calculation, understanding and constructive praxis [25].
Geriatric Depression Scale (GDS-15)
This questionnaire was specifically developed for older
patients and consists of 15 questions that assess the
functional and mood-associated symptoms of depression
[26-28].
Activities of Daily Living (ADL)
Functional limitations are assessed by determining the
degree of difficulty of carrying out six everyday activities.
The answers vary between (1) “No, I cannot do this” to
(5) “Yes, without any problems”. The total score varies
between 6 (minimum) and 30 (maximum) [29].
Tinetti test
This consists of a number of tests concerning move-
ment and balance. Individual aspects are scored between
0 and 2, for a total score of 28 points. This test detects
patients with an increased risk of falling [30].
LASA Physical Activity Questionnaire (LAPAQ)
The LAPAQ questionnaire assesses the frequency and
duration of walking outside, cycling, gardening, light
and heavier housework and sporting activities over the
previous two weeks. The duration of each of these activ-
ities is investigated and scored. The total LAPAQ score
is calculated by multiplying the frequency and duration
of the various aspects by one another [31].
Performance tests
The number of seconds the patient requires to complete
each test is recorded [32].
￿ Performance test 1: walking test: the patient is
asked to walk as quickly as they can for 3 metres,
then turn and walk back 3 metres.
￿ Performance test 2: chair test: the patient is asked
to stand up and sit down again five times with their
arms crossed as quickly as possible.
￿ Performance test 3: cardigan test: the patient is
asked to remove a cardigan as quickly as possible.
Calculating ABI
At the completion of the examination, ABI was measured
by the GP with the aid of an automatic oscillometric appli-
ance (SCVL-2007, Diegel Healthworks
® and associated
software). Participating GP’s were trained to standardise
the ABI measurement. The patient was placed in the
supine position, and a pressure cuff was placed around the
arm and leg, first on the left side and then on the right
side. The pressure cuffs were simultaneously, automati-
cally inflated by the software, and both the systolic and the
diastolic blood pressures were measured at the arm and
leg. ABI was calculated as the quotient between the systo-
lic blood pressure at the ankle and the systolic blood pres-
sure at the arm. A value of 0.9 or more was viewed as
normal, a value of less than 0.9 was considered a reduced
ABI [5]. Afterwards, the ABI measurement was reported
back to the treating GP and all physicians were referred to
existing guidelines on PAD for follow-up [2].
Data analysis
Differences between patients with and without a recorded
ABI and between patients with and without a reduced ABI
were calculated with the independent Student’s t-test and
the Mann-Whitney U test for non-normally distributed
variables. A P-value of < 0.05 was considered statistically
significant.
The Jonckheere-Terpstra test was used to compare the
median ABI values between different categories of
patients with increasing numbers of cardiovascular risk
factors and cardiovascular morbidities.
The sensitivity, specificity, negative predictive value
(NPV) and positive predictive value (PPV) of the medi-
cal history and the clinical examination for an ABI of <
0.9 were calculated with the help of 2 × 2 tables. At the
same time, we calculated the number of reduced ABI
values we would have missed and the number of nega-
tive examination results we would have gotten if we had
used the medical history and clinical examination to
select patients for ABI measurement.
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Patient population and prevalence
In Hoeilaart 239 patients participated in the BELFRAIL
study (Figure 1). In 175 of the participants, an ABI was
calculated for at least one leg. In the remaining 64 parti-
cipants, ABI was not measured for a variety of reasons,
i n c l u d i n gp a i ni nt h el e gw h e nt h ec u f fw a si n f l a t e d ,
extensive oedema of the lower leg, and a failed oscillo-
metric blood pressure reading in the lower leg despite
repeated attempts.
Table 1 lists the differences between patients with and
without ABI readings. The patients who did not have
any readings taken were institutionalised more fre-
quently (P <0 . 1 0 )a n do na v e r a g eh a dal o w e rl e v e lo f
education (P < 0.10). MMSE score was also lower in the
group who were not examined (P < 0.05). There was no
difference in the clinical characteristics between the two
patient groups.
In 23 patients, ABI was measured in only one leg. ABI
was measured in a total of 327 legs. For six of the legs,
ABI was > 1.5, and these results were excluded from
further analysis. In 94 of the 327 legs, ABI of < 0.9
(29.7%) was found. Of the 175 patients, 70 had at least
one leg with an ABI of < 0.9 (40%).
Diagnostic value of cardiovascular morbidity and a
clinical examination for low ABI
Table 2 shows the differences in cardiovascular burden
between patients with a low and a normal ABI. The
average age was higher in the group with a low ABI.
The presence of cardiovascular risk factors was preva-
lent but did not differ between the two groups, nor was
there a correlation between the number of risk factors
and ABI (Figure 2). The presence of a cardiovascular
risk factor as an identifier of low ABI had a high sensi-
tivity (92.9%) and a low specificity (12.4%) (Table 3). If
ABI had been determined only for patients with at least
one cardiovascular risk factor 7% (5/70) of the patients
with ABI < 0.9 would have been missed and 59%
(92/157) would have had a normal result.
T h ep r e v a l e n c eo fc a r d i a cm o rbidity was significantly
higher in patients with low ABI. More specifically, the
numbers of myocardial infarctions and cardiac stents
were higher in patients with ABI < 0.9. In 13 (18.6%)
patients with a low ABI, there had already been a diag-
nosis of PAD, and 4 (3.8%) patients with a diagnosis of
PAD had a normal ABI. A negative correlation was
found between the number of cardiovascular (cardiac
and other) morbidities and ABI. The median ABI
Table 1 Comparison between patients with and without an ABI recorded
ABI measured P*
Yes (n = 175) No (n = 64)
Sociodemographic characteristics
Men (n, %) 64 (36.6) 20 (31.2) 0.45
Age (mean ± SD) 84.9 ± 3.9 85.1 ± 3.7 0.78
Institutionalised (n, %) 10 (5.7) 9 (14.1) 0.081
≤ Lower secondary education (n, %) 130 (74.3) 54 (84.4) 0.076
Functioning
MMSE (median, IQR) 28 (26 - 29) 27 (24 - 29) 0.011
£
ADL (median, IQR) 25 (21 - 27) 25 (20 - 27) 0.96
£
GDS-15 (median, IQR) 2 (1 - 4) 2 (1 - 3) 0.32
£
Performance tests (median, IQR) 8 (5 - 11) 9 (4 - 12) 0.57
£
LAPAQ (median, IQR) 84.0 (38.5 - 106) 71.5 (44.5 - 106.5) 0.64
£
Tinetti (median, IQR) 27 (25 - 28) 27 (25 - 28) 0.82
£
Clinical characteristics
Hypertension (n, %) 131 (74.9) 47 (73.4) 0.83
Hyperlipidaemia (n, %) 70 (40.0) 28 (43.8) 0.60
Diabetes (n, %) 36 (20.6) 18 (28.1) 0.24
Smoker, current or ex- (n, %) 55 (31.4) 18 (28.1) 0.63
BMI ≥30 (n, %) 48 (27.7) 15 (23.4) 0.51
Angina pectoris (n, %) 31 (17.7) 11 (17.2) 0.93
Myocardial infarction (n, %) 20 (11.4) 9 (14.1) 0.58
TIA or CVA (n, %) 32 (18.3) 10 (15.6) 0.63
Known PAD (n, %) 17 (9.7) 5 (7.8) 0.65
Arterial surgery (n, %) 8 (4.6) 2 (3.1) 0.62
* Independent Student’s t-test; IQR, inter-quartile range;
£, Mann-Whitney U test;
$. ABI: ankle-brachial index; SD: standard deviation; MMSE: Mini-Mental State
Examination; ADL: Activities of Daily Living; GDS: Geriatric Depression Scale; LAPAQ: LASA Physical Activity Questionnaire; BMI: body mass index; TIA: transient
ischaemic attack; CVA: cerebro-vascular accident; PAD: peripheral arterial disease.
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morbidities to 0.99 [IQR 0.78-1.1] in patients with one
morbidity, 0.93 [IQR 0.78-1.1] with two morbidities,
0.84 [IQR 0.68-0.95] with three morbidities and 0.76
[IQR 0.54-0.89] in patients with four or more morbid-
ities (Jonckheere-Terpstra, P < 0.001) (Figure 2).
The presence of a cardiovascular morbidity had a
sensitivity of 65.7% and a specificity of 48.6%. If the
cardiovascular history had been used to select patients
for an ABI reading, 34.3% (24/70) would have been
missed and 54% (54/100) of the patients investigated
would have been diagnosed with a normal ABI. If an
ABI determination had been completed for only
patients with three or more morbidities, the specifi-
city and PPV of the test would have increased; how-
ever, 70% of the subjects with ABI < 0.9 would be
missed.
The highest NPV was found for the clinical examina-
tion (77.7%). In 46 (26.6%) patients, no peripheral
pulse was observed in the right leg; in 52 (30.1%)
patients, no peripheral pulse was observed in the left
leg. If the presence of peripheral pulses had been used
to select patients for an ABI reading, 54% (51/94)
would have been missed and 51% (45/88) would have
been diagnosed with a normal ABI. Combining the
cardiovascular morbidity with a positive clinical exami-
nation did not increase the NPV and only slightly
increased the PPV.
Function and physical activity
Table 4 displays the differences in function and physical
activity between patients with a low ABI and normal
ABI. No significant difference in function was found
between the two groups. However, a trend of lower
scores for everyday activities was observed in patients
with ABI < 0.9.
The performance tests, which were short exertion
tests, did not reveal differences between the patients
with a normal and low ABI.
The LAPAQ score, which recorded more extensive
exertions, did show a significantly lower score in the
group with a low ABI.
Discussion
Patient population and prevalence
This study was carried out on a representative sample of
people aged 80 and older as more than 95% of the
population in Belgium is reported to consult the same
GP or practice in case of health problems and more
than 90% of people aged 65 and older have at least one
contact with their GP every year, with an average of
11.9 contacts per year at the age of 75 and older [33]. In
40% of the patients investigated, a low ABI was found in
at least one leg. This prevalence is somewhat greater
than the prevalence found in other studies. Studies
involving exclusively subjects aged 80 and over are lim-
ited. A Finnish study found a prevalence of 22% in
Table 2 Comparison of the cardiovascular burden between patients with ABI < 0.9 and ABI ≥0.9.
ABI < 0.9 (n = 70) ABI ≥ 0.9 (n = 105) P*
Men (n, %) 29 (41.4) 35 (33.3) 0.28
Age (mean ± SD) 85.7 ± 4.8 84.4 ± 3.2 0.044
Cardiovascular risk profile (n, %) 65 (92.9) 91 (88.3) 0.31
Hypertension (n, %) 54 (77.1) 77 (73.3) 0.57
Hyperlipidaemia (n, %) 24 (34.3) 46 (43.8) 0.21
Diabetes (n, %) 14 (20.0) 22 (21.0) 0.88
Smoker, current or ex- (n, %) 26 (37.1) 29 (27.6) 0.19
BMI ≥ 30 (n, %) 15 (21.4) 33 (32.0) 0.12
Cardiac morbidity (n, %) 42 (60.0) 41 (39.0) 0.006
Angina pectoris (n, %) 16 (22.9) 15 (14.3) 0.16
Myocardial infarction (n, %) 13 (18.6) 7 (6.7) 0.026
Episode of decompensated heart failure (n, %) 6 (8.6) 6 (5.7) 0.47
Chronic atrial fibrillation (n, %) 11 (15.7) 10 (9.5) 0.24
Rhythm disorder (n, %) 16 (22.9) 16 (15.2) 0.22
PTCA - stent (n, %) 9 (12.9) 5 (4.8) 0.077
Coronary surgery (n, %) 3 (4.3) 4 (3.8) 0.88
Other cardiovascular morbidity (n, %) 21 (30.0) 21 (20.0) 0.14
TIA of CVA (n, %) 12 (17.1) 20 (19.0) 0.75
PAD (n, %) 13 (18.6) 4 (3.8) 0.004
Arterial surgery (n, %) 7 (10.0) 1 (1.0) 0.018
* Independent Student’s t-test.
ABI: ankle-brachial index; SD: standard deviation; BMI: body mass index; PTCA: percutaneous transluminal coronary angioplasty; TIA: transient ischaemic attack;
CVA: cerebro-vascular accident; PAD: peripheral arterial disease.
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lence of 19.7% in the 80-84 age group and 40% in those
aged 85 and over [35]. All of these were small studies
on a limited number of oldest old patients. In a larger
cohort study Diehm et al. confirmed PAD in 141 of 545
patients between the ages of 80 and 84 (25.9%) and in
42 of 130 of patients over 85 (32.3%) [10].
Diagnostic value of cardiovascular comorbidity and
clinical examination for low ABI
This study found no correlation between a low ABI and
the presence of cardiovascular risk factors in patients
aged 80 and over. However, hypothetical selection on
the basis of cardiovascular risk factors did provide an
acceptable NPV and a low number of missed cases. This
is predominantly explained by the high prevalence of
risk factors in this age group; thus, this selection method
results in a large number of negative examinations.
These findings agree with the results from the Leiden
85-Plus study, which demonstrated that the Framingham
risk factors no longer succeed in predicting cardiovascu-
l a rm o r t a l i t yf o rp a t i e n t so v e rt h ea g eo f8 5[ 3 6 ] .T h e s e
results might indicate that classic cardiovascular risk
factors can no longer be used for predicting cardiovas-
cular morbidity and mortality in the elderly.
However, a difference was found in the prevalence of
cardiovascular morbidity between the two ABI groups.
As the number of cardiovascular morbidities increased,
the likelihood of measuring a low ABI increased. In con-
trast, it was difficult to identify patients with ABI < 0.9
on the basis of known cardiovascular morbidity.
Furthermore, an increase in the number of cardiovascu-
lar morbidities did not increase the diagnostic value.
The clinical examination of the GP showed an accep-
table specificity and NPV; however, if the absence of
peripheral pulses had been used to rule out a low ABI
then more than 50% of the cases would have been
missed. These results are in agreement with previous
studies. Cacoub et al. showed that in the absence of a
Figure 2 Correlations between ABI and the number of
cardiovascular risk factors and the number of cardiac and
other cardiovascular comorbidities. P for trend = Jonckheere-
Terpstra test. ABI: ankle-brachial index.
Table 3 Diagnostic value of the cardiovascular risk profile, known cardiovascular history and the clinical examination
for low ABI
Test Sens, % (95%
CI)
Spec, % (95%
CI)
NPV, % (95%
CI)
PPV, % (95%
CI)
Missed cases
(%)
Negative ABI
(%)
CV risk factor*, n ≥ 1 92.9 (84.1-97.6) 12.4 (6.8-20.2) 72.2 (46.5-90.2) 41.4 (33.6-49.5) 5/70 (7.1) 92/157 (58.6)
CV morbidity*, n ≥ 1 65.7 (53.4-76.7) 48.6 (38.7-58.5) 68.0 (56.2-78.3) 46.0 (36.0-56.3) 24/70 (34.3) 54/100 (54.0)
CV morbidity*, n ≥ 3 27.1 (17.2-39.1) 92.4 (85.5-96.6) 65.5 (57.3-73.2) 70.4 (49.8-86.2) 51/70 (72.9) 8/27 (29.6)
Cardiac morbidity, n ≥ 1 60.0 (47.6-71.5) 61.0 (50.9-70.3) 69.6 (59.1-78.7) 50.6 (39.4-61.8) 28/70 (40.0) 41/83 (49.4)
Other CV morbidity, n ≥ 1 30 (19.6-42.1) 80 (71.1-87.2) 63.2 (54.4-71.4) 50.0 (34.2-65.8) 49/70 (70.0) 21/42 (50.0)
Clinical examination
$ 45.7 (35.4-56.3) 79.8 (74.0-84.9) 77.7 (71.8-82.9) 48.9 (38.1-59.8) 51/94 (54.3) 45/88 (51.1)
Cardiac morbidity* (n ≥ 1) AND Clinical
examination
$
35.1 (25.5-45.6) 87.0 (81.9-91.1) 76.1 (70.4-81.2) 53.2 (40.1-66.0) 61/94 (64.9) 29/62 (46.8)
*Prevalence of ABI < 0.90 was 40%,
$ Prevalence of ABI < 0.9 was 29.7%. ABI: ankle-brachial index; Sens: sensitivity; CI: confidence interval; Spec: specificity; NPV:
negative predictive value; PPV: positive predictive value; CV: cardiovascular.
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sions could be drawn [37,38]. Khan et al. concluded in a
meta-analysis that the clinical examination in itself was
not sufficient to confirm or exclude PAD with any
degree of certainty [39].
A low ABI in elderly people can be considered a marker
for cardiovascular disease and a predictor for mortality
and cardiovascular morbidity [8-14]. As the presence of
known cardiovascular morbidity did not provide the ability
to differentiate between patients with a low and a normal
ABI, a low ABI could possibly be an indicator of unrecog-
nised cardiovascular disease. In this study, 24 (34.3%)
patients who had a low ABI had no known cardiovascular
morbidity.
The effectiveness of possible interventions after finding
a low ABI in patients aged 80 and over remains unclear.
The treatment of PAD consists of an optimal treatment
for classic cardiovascular risk factors, such as hyperten-
sion, hyperlipidaemia, diabetes mellitus, and stopping
smoking, including the use of antiaggregants and walking
exercises. These measures have a proven beneficial effect
on younger patients up to the age of 75 [40]; however, no
intervention studies currently exist for patients aged 80
and over. On the other hand, advances in endovascular
interventions have expanded the options available for the
invasive treatment of PAD the last few years. Although
no causal link has yet been established, major lower
extremity amputation rates have fallen by more than 25%
during this time period [41].
The U.S. Preventive Services Task Force (USPSTF)
recommends against routine screening for PAD among
asymptomatic adults in the general population because
the prevalence of PAD in this group is low and because
there is little evidence that treatment of PAD at this
asymptomatic stage of disease, beyond treatment based
on standard cardiovascular risk assessment, improves
health outcomes [42]. The present study, however,
showed a high prevalence of PAD, symptomatic or
asymptomatic, in a selected population of subjects aged
80 and over. The identification of the presence or
absence of a low ABI on the basis of known cardiovascu-
lar morbidity and a clinical examination appeared to be
difficult. Moreover, it appeared that 80% of patients with
a low ABI were not yet diagnosed with PAD, probably
due to the great number of patients at a sub-clinical
stage. Furthermore, an oscillometric ABI measurement is
simple to carry out, has been validated in several studies
[17-20], and could easily be integrated in a GP consulta-
tion. Therefore, a screening program for PAD among
people aged 80 and over could be considered, if effective
interventions resulted from further research.
Function and physical activity
Lower-extremity function is an important predictor of
future disability, mobility loss, and nursing home place-
ment [32,43]. This study showed physical activity
assessed with performance tests, which measured short
periods of exertion, was the same for patients with a low
and a normal ABI. This result was to be expected, as
PAD normally exhibits an onset of symptoms after a
longer period of exertion. The physical activity, assessed
by the LAPAQ questionnaire, which records extended
exertion, was significantly lower in those patients with a
low ABI. This is in line with the results from the
WALCS-study, in which patients with and without PAD
were subjected to a 6 minute walking test. That study
showed a strong correlation amongst ABI, the function
of the lower limbs and the reduced mobility of the
patient. Calculation of ABI detected more people with
reduced mobility than the clinical criteria for intermittent
claudication [44]. Therefore, a low ABI may identify per-
sons whose high risk for mobility loss and nursing home
placement might otherwise go unrecognized. These find-
ings suggest interventions to prevent mobility loss and
Table 4 Difference in function and physical activity between patients with a low ABI and patients with a normal ABI
ABI < 0.9
(n = 70)
ABI ≥ 0.9
(n = 105)
P*
Institutionalised (n, %) 6 (8.6) 4 (3.8) 0.19
$
MMSE (median, IQR) 28 (26-29) 28 (25-29) 0.29
ADL (median, IQR) 25 (22-27) 24 (19-27) 0.073
GDS-15 (median, IQR) 2 (1-4) 2 (1-4) 0.41
Tinetti (median, IQR) 27 (26-28) 27 (24-28) 0.29
Performance tests
Performance test 1 (median, IQR) 13.4 (9.4-18.9) 13.0 (9.9-16.3) 0.41
Performance test 2 (median, IQR) 14.5 (10.9-19.0) 14.2 (11.1-17.9) 0.90
Performance test 3 (median, IQR) 14.4 (11.2-17.7) 13.6 (10.5-17.8) 0.80
LAPAQ (median, IQR) 70 (28-99) 88 (48-108) 0.023
*Mann-Whitney U test;
$, independent Student’s t-test.
ABI: ankle-brachial index; MMSE: Mini-Mental State Examination; IQR: inter-quartile range; ADL: Activities of Daily Living; GDS: Geriatric Depression Scale; LAPAQ:
LASA Physical Activity Questionnaire.
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sons with low ABI [44].
Strengths and limitations
The strength of this study is that it was carried out on an
unselected first-line population and is a clear reflection of
everyday practice. A large number of patients, representa-
tive of people aged 80 and over in Belgium, were exam-
ined. Furthermore, this study is the first to investigate
whether a GP could identify those patients aged 80 and
over with a low ABI using the history of known cardiovas-
cular disease and a clinical examination.
This study has a number of limitations. 1) The ABI
measurement and the clinical examination were carried
out by the same doctor. Thus, the results of the clinical
examination and the ABI were not blinded. 2) No details
regarding the symptoms of intermittent claudication
were available. However, in 80% of the patients with a
low ABI there was no previous history of PAD. 3) A low
ABI is used as the ‘gold standard’ for PAD. Although
arteriography is generally seen as the gold standard for
PAD, it is apparent from the literature that a low ABI
correlates well with arteriography findings; a sensitivity of
91% and a specificity of 86% were documented [6]. More-
over, the oscillometric method is a validated method for
determining ABI [17-20].
Conclusion
This study shows that the prevalence of low ABI, clini-
cal or subclinical, is high in patients aged 80 and over in
general practice.
It was clearly demonstrated that the clinical examina-
tion, the presence of cardiovascular risk factors and the
presence of cardiovascular morbidity do not identify
patients with a low ABI in general practice. A screening
strategy for PAD using the determination of ABI could be
considered if effective interventions resulted from further
research for those aged 80 and over with a low ABI.
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